New research published in The Journal of Clinical Investigation argues that Alzheimer’s may begin much earlier than ...

For Kathy Small Wrice, a 20-year journey with multiple myeloma began not with a clear answer, but with a persistent intuition. Following her dream wedding in Malta, the Minneapolis native faced a ...

A new class of weight loss drug just took a major step toward approval for use. In a phase III clinical trial, medication ...

One key failure mechanism is the logistic implementation for the DCT trials. A lot of times, when you go to a global trial, there's a lot of logistic management for DCT. Let's say you must ship the ...

A new analysis represents the largest effort yet to systematically parse all the data from high-quality clinical trials on cannabis and mental health. The evidence is lacking.

The FDA’s recent announcement to reduce, and in some cases replace, animal testing for monoclonal antibodies and other therapeutics represents one of the most consequential regulatory developments in ...

As of Friday, March 13, The Oncology Institute, Inc.’s TOI share price has surged by 25.00%, which has investors questioning if this is right time to sell.

They’re marketed as a natural alternative to prescription drugs and are popular on social media, but do they work?

US-supported international HIV research, particularly that conducted in African countries, has direct benefits to Americans. Cuts to that research may undermine those benefits.

Scientists want to redesign psychedelics so that they don’t induce a trip—but they still improve mental health.